1. The development and pilot of ‘Delta’: supporting parents and young people deciding whether to enrol in a paediatric oncology clinical trial
- Author
-
Robertson, Eden
- Subjects
- Clinical trials, Decision making, Paediatric oncology, Childhood cancer, Decision aid
- Abstract
Clinical trials have been fundamental to improving outcomes for children with cancer. However, the enrolment process is complex for families and healthcare professionals. This thesis used a mixed-methods, multi-perspective approach to guide the development and evaluation of ‘Delta’. Delta is the world’s first decision aid to support parents with a child with cancer and adolescents with cancer deciding whether to enrol in a clinical trial. In Chapter 1, I present an overview of the clinical trials. This chapter addresses the complexity of the decision-making process for families, and discusses the benefits of patient decision aids. In Chapter 2, I conduct a systematic review of 17 studies to identify recommendations to facilitate shared decision-making regarding paediatric oncology clinical trials. In Chapter 3, I interview 25 parents and 5 adolescents recently after diagnosis to explore their decision-making experiences. In Chapter 4, I survey 87 Australian and New Zealand healthcare professionals about their experiences enrolling children with cancer into an early-phase clinical trial. In Chapter 5, I present a process map from the point of a child’s relapse to treatment decision at one of Australia’s largest paediatric oncology units. The findings from Chapters 2 to 5 guided the development of Delta. In Chapter 6, I describe the development and the findings from user-testing with seven parents and six healthcare professionals. In Chapter 7, I present a narrative review to identify the most appropriate measures to evaluate a paediatric decision-making intervention. Using the findings from Chapter 7, I conduct a before–after pilot evaluation of Delta with 37 parents and 3 adolescents who had recently enrolled in a clinical trial (Chapter 8). Participants rated Delta as acceptable, and reported that it should be available to all families making an enrolment decision. Parents had higher levels of objective clinical trial knowledge after reading Delta compared to baseline (odds ratio=2.25; 95% CI:1.66-3.04; p
- Published
- 2019